221 results
Page 2 of 12
8-K
EX-99.1
byceq70o
8 Dec 22
GeoVax Appoints Jayne Morgan, M.D., to its Board of Directors
3:53pm
8-K
EX-99.1
197d1ua rnly
14 Nov 22
GeoVax Reports 2022 Third Quarter
6:09am
8-K
EX-99.2
3rrb7v fyb9e
14 Nov 22
GeoVax Reports 2022 Third Quarter
6:09am
8-K
EX-99.2
2lak1f
4 Aug 22
GeoVax Reports 2022 Second Quarter Financial Results
4:06pm
8-K
EX-99.1
njz0 w730
4 Aug 22
GeoVax Reports 2022 Second Quarter Financial Results
4:06pm
424B3
7ob7u
27 Jun 22
Prospectus supplement
9:13am
8-K
EX-10.1
iqq9irh8hh
27 May 22
GeoVax Announces $20 Million Registered Direct and PIPE Offerings Priced at a Premium to Market Under Nasdaq Rules
4:48pm
8-K
EX-10.5
ejq0tr8
27 May 22
GeoVax Announces $20 Million Registered Direct and PIPE Offerings Priced at a Premium to Market Under Nasdaq Rules
4:48pm
8-K
EX-10.4
hd2x lxb3dsukyt
27 May 22
GeoVax Announces $20 Million Registered Direct and PIPE Offerings Priced at a Premium to Market Under Nasdaq Rules
4:48pm
424B5
3n1wuf
27 May 22
Prospectus supplement for primary offering
8:49am
8-K
EX-99.1
x0ao2
2 May 22
GeoVax Reports 2022 First Quarter Financial Results
7:30am
8-K
EX-99.1
1stjhe8r
10 Mar 22
GeoVax Reports 2021 Year-End Financial Results
5:02pm
POS AM
krffnj2q2r qyn2hg
9 Mar 22
Prospectus update (post-effective amendment)
8:42pm
POS AM
7sdlz0
9 Mar 22
Prospectus update (post-effective amendment)
8:40pm